Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

α-particle

  • Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer
    Open Access
    Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer
    Nadia Benabdallah, Peng Lu, Diane S. Abou, Hanwen Zhang, David Ulmert, Robert F. Hobbs, Hiram A. Gay, Brian W. Simons, Muhammad A. Saeed, Buck E. Rogers, Abhinav K. Jha, Yuan-Chuan Tai, Christopher D. Malone, Joseph E. Ippolito, Jeff Michalski, Jack W. Jennings, Brian C. Baumann, Russell K. Pachynski and Daniel L.J. Thorek
    Journal of Nuclear Medicine February 1, 2024, 65 (2) 245-251; DOI: https://doi.org/10.2967/jnumed.123.266571
  • Estimating the Risk for Secondary Cancer After Targeted α-Therapy with <sup>211</sup>At Intraperitoneal Radioimmunotherapy
    Open Access
    Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy
    Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm and Per Albertsson
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 165-172; DOI: https://doi.org/10.2967/jnumed.121.263349
  • Preclinical Evaluation of <sup>213</sup>Bi- and <sup>225</sup>Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer
    You have access
    Preclinical Evaluation of 213Bi- and 225Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer
    Sangeeta Ray Banerjee, Ala Lisok, Il Minn, Anders Josefsson, Vivek Kumar, Mary Brummet, Srikanth Boinapally, Cory Brayton, Ronnie C. Mease, George Sgouros, Robert F. Hobbs and Martin G. Pomper
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 980-988; DOI: https://doi.org/10.2967/jnumed.120.256388
  • You have access
    Preclinical Evaluation of 203/212Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
    Sangeeta Ray Banerjee, Il Minn, Vivek Kumar, Anders Josefsson, Ala Lisok, Mary Brummet, Jian Chen, Ana P. Kiess, Kwamena Baidoo, Cory Brayton, Ronnie C. Mease, Martin Brechbiel, George Sgouros, Robert F. Hobbs and Martin G. Pomper
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 80-88; DOI: https://doi.org/10.2967/jnumed.119.229393
  • You have access
    Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with 223Ra: The Role of Bystander Effects and Their Potential for Therapy
    Calvin N. Leung, Brian S. Canter, Didier Rajon, Tom A. Bäck, J. Christopher Fritton, Edouard I. Azzam and Roger W. Howell
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 89-95; DOI: https://doi.org/10.2967/jnumed.119.227835
  • Open Access
    Evidence of Local Concentration of α-Particles from 211At-Labeled Antibodies in Liver Metastasis Tissue
    Satoshi Kodaira, Yukie Morokoshi, Huizi Keiko Li, Teruaki Konishi, Mieko Kurano and Sumitaka Hasegawa
    Journal of Nuclear Medicine April 1, 2019, 60 (4) 497-501; DOI: https://doi.org/10.2967/jnumed.118.216853
  • You have access
    213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma
    Michel Chérel, Sébastien Gouard, Joëlle Gaschet, Catherine Saï-Maurel, Frank Bruchertseifer, Alfred Morgenstern, Mickael Bourgeois, Jean-François Gestin, Françoise Kraeber Bodéré, Jacques Barbet, Philippe Moreau and François Davodeau
    Journal of Nuclear Medicine September 1, 2013, 54 (9) 1597-1604; DOI: https://doi.org/10.2967/jnumed.112.111997
SNMMI

© 2025 SNMMI

Powered by HighWire